MIA and metastatic neoplasm: Increased MIA serum level is related to metastatic disease or tumour recurrence99; it also likely represents a key molecule that regulates melanoma progression.100 NONO is a downstream target of MIA, and MIA knock‐down reduces NONO expression at both the mRNA and protein levels.